S Deandrea

Summary

Affiliation: Istituto di Ricerche Farmacologiche Mario Negri
Country: Italy

Publications

  1. ncbi Prevalence of undertreatment in cancer pain. A review of published literature
    S Deandrea
    Laboratory of Epidemiological Methods, Department of Epidemiology, Mario Negri Institute for Pharmacological Research, Milan, Italy
    Ann Oncol 19:1985-91. 2008
  2. ncbi Pattern and quality of care of cancer pain management. Results from the Cancer Pain Outcome Research Study Group
    G Apolone
    Center for the Evaluation and Research on Pain CERP Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
    Br J Cancer 100:1566-74. 2009
  3. ncbi Managing severe cancer pain: the role of transdermal buprenorphine: a systematic review
    S Deandrea
    Center for the Evaluation and Research on Pain CERP, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
    Ther Clin Risk Manag 5:707-18. 2009

Detail Information

Publications3

  1. ncbi Prevalence of undertreatment in cancer pain. A review of published literature
    S Deandrea
    Laboratory of Epidemiological Methods, Department of Epidemiology, Mario Negri Institute for Pharmacological Research, Milan, Italy
    Ann Oncol 19:1985-91. 2008
    ..Pain Management Indexes (PMIs) evaluate the congruence between the patient's reported level of pain and the intensity/strength of the analgesic therapy. Negative scores indicate inadequate prescriptions...
  2. ncbi Pattern and quality of care of cancer pain management. Results from the Cancer Pain Outcome Research Study Group
    G Apolone
    Center for the Evaluation and Research on Pain CERP Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
    Br J Cancer 100:1566-74. 2009
    ....
  3. ncbi Managing severe cancer pain: the role of transdermal buprenorphine: a systematic review
    S Deandrea
    Center for the Evaluation and Research on Pain CERP, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
    Ther Clin Risk Manag 5:707-18. 2009
    ..In conclusion, although the narrative appraisal of each study suggests a positive risk benefit profile, well designed and statistically powered controlled clinical trials are needed to confirm this preliminary evidence...